MedPath

Post operative pain relief for all upper limb surgeries by comparing two local anaesthetic drugs

Not Applicable
Conditions
Health Condition 1: 7- OsteopathicHealth Condition 2: 7- OsteopathicHealth Condition 3: M958- Other specified acquired deformities of musculoskeletal system
Registration Number
CTRI/2024/03/063512
Lead Sponsor
SREE BALAJI MEDICAL COLLEGE AND HOSPITA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients receiving 0.25% Levobupivacaine with 1mcg/kg Dexmedetomidine group L

Patients receiving 0.375% Ropivacaine with 1mcg/kg Dexmedetomidine group R

ASA Grade I and II

All age groups

Obese patients

Patients posted for elective surgeries

Exclusion Criteria

ASA III and IV

Known case of hypersensitivity reaction to local anesthetics

Bleeding diathesis and Peripheral neuropathy and neuromuscular disease and psychiatric disorders

Local infection at the site of puncture

Patients with polytrauma

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
It is an observational study to find out whether 0.25% levobupivacaine 1mcg/kg Dexmedetomidine or 0.375% ropivacaine with 1mcg/kg Dexmedetomidine has the early onset of sensory and motor blockade prolonged duration of analgesia and better hemodynamic stabilityTimepoint: 0 hours and 1 hour till 10 hours
Secondary Outcome Measures
NameTimeMethod
duration of analgesia & to assess better hemodynamic stability.Timepoint: at 30mins 1hour 2hour 3hour
© Copyright 2025. All Rights Reserved by MedPath